Assessment of ocular and systemic complcations after intravitreal bevacizumab injection for macular edema in branch retinal vein occlusion
Background: Intravitreal bevacizumab is being used for macular edema caused by retinal vascular diseases. There is no long-term information on safety and adverse effects of the drug used for intraocular purposes in Pakistan. The purpose of this study was to assess the ocular and systemic complicatio...
Main Authors: | Yasir Iqbal, Sohail Zia |
---|---|
Format: | Article |
Language: | English |
Published: |
Gomal Medical College, D.I.Khan, Pakistan
2012-07-01
|
Series: | Gomal Journal of Medical Sciences |
Online Access: | http://gjms.com.pk/ojs24/index.php/gjms/article/view/539 |
Similar Items
-
Intravitreal bevacizumab injection in the treatment of macular edema secondary to branch retinal vein occlusion
by: Şeref İstek, et al.
Published: (2014-06-01) -
Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
by: Thapa R, et al.
Published: (2012-07-01) -
Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
by: Demir M, et al.
Published: (2011-06-01) -
Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
by: Jia-Kang Wang, et al.
Published: (2016-01-01) -
The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
by: Gokce G, et al.
Published: (2014-02-01)